Monobenzyl Ether of Hydroquinone in Depigmentation of Vitiligo.
Phase 4
- Conditions
- Skin and Connective Tissue Diseases
- Registration Number
- PACTR201808699550182
- Lead Sponsor
- Vitiligo unit Dermatology department Cairo university
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
?Age above 12 years, both sexes.
?Vitiligo patients with >50% body surface area (BSA) involvement retaining few small areas of normal color on face and/or hands.
?Vitiligo patients with <50% BSA involvement who are refractory to treatment and aspire at improving aesthetically on face and/or hands.
Exclusion Criteria
?Segmental Vitiligo.
?Vitiligo responsive to treatment.
?Pregnant or breastfeeding women.
?Known allergy to MBEH.
?Hepatic or renal diseases.
?Concomitant oral corticosteroid or immunosuppressive therapy.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method